NOVATO, Calif., May 8, 2012 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) announced today the appointment of Dan Spiegelman as Executive Vice President and Chief Financial Officer (CFO). Mr. Spiegelman will replace longtime BioMarin CFO, Jeffrey Cooper, at the end of the month.
